LYNX PHARMA AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−585k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−11k kr).
LYNX PHARMA AS is registered as a limited company in Færder, Vestfold with organisation number 931174673. The business is classified under other health services (NACE 86.993). The company was incorporated in 2023. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Selge tjenester og varer innen legetjenester, helse, skjønnhet og velvære og annet som naturlig sammenfaller med dette, samt deltakelse i andre selskaper, investeringer og nærliggende virksomhet.”.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns LYNX PHARMA AS?
LYNX PHARMA AS has 1 registered shareholder:
- YTRE HATTHOLMEN AS 100.0%
Frequently asked questions about LYNX PHARMA AS
Who owns LYNX PHARMA AS?
YTRE HATTHOLMEN AS is the largest registered owner, with 100.0%.
Who is the general manager of LYNX PHARMA AS?
Henrik Aasrum Svendsen is registered as general manager of LYNX PHARMA AS.
Where is LYNX PHARMA AS based?
LYNX PHARMA AS has its business address in Torød.
Property
2 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.